Sundaresan S, Alevy Y G, Steward N, Tucker J, Trulock E P, Cooper J D, Patterson G A, Mohanakumar T
Department of Surgery, Washington University School of Medicine/Barnes Hospital, St. Louis, Mo, USA.
J Heart Lung Transplant. 1995 May-Jun;14(3):512-8.
Cytokines participate in host responses to allografts, largely through recruiting and activating various regulatory and effector cells. We performed this study to determine the feasibility of using polymerase chain reaction methodology to define the expression of three important cytokines (tumor necrosis factor-alpha, interleukin-2, and interferon-gamma) in human pulmonary allografts.
Twenty-six graft-derived samples (11 transbronchial biopsy and 8 macrophage and 7 lymphocyte cell pellets isolated from bronchoalveolar lavage) were obtained from 13 lung transplant recipients and treated as follows: extraction of RNA; reverse transcription of RNA to complementary DNA; polymerase chain reaction amplification of cDNA with oligonucleotide primers specific for the three cytokines; gel electrophoresis of the polymerase chain reaction products; and verification of correct cytokine message by Dot blot technique (with specific 32P-labeled oligonucleotide probes).
Concomitant pathologic evaluation of biopsy specimens from these 13 recipients showed five diagnostic groups: "normal" (no rejection/infection), n = 2; acute rejection, n = 4; nonspecific inflammation, n = 3; infection, n = 3; and obliterative bronchiolitis, n = 1. Interleukin-2 was expressed predominantly in acute rejection and infection (seven of ten and five of six samples positive, respectively), whereas tumor necrosis factor-alpha was expressed mainly in nonspecific inflammation (four of five samples) and somewhat less in rejection (six of ten). Interferon-gamma was expressed less frequently (in two of six samples with infection, but in none of ten with rejection and none of five with nonspecific inflammation). Serial data from one patient (6 months apart) showed considerable increase in interleukin-2 and interferon-gamma expression as she progressed from normal histologic status to obliterative bronchiolitis.
Cytokine gene transcripts can be determined from minute samples derived directly from pulmonary allografts. Although our data are insufficient to make definitive conclusions, the suggestion of trends of cytokine expression in different posttransplantation pathologic conditions may indicate a useful role for this approach in the clinical evaluation of the lung transplant recipient.
细胞因子主要通过募集和激活各种调节细胞及效应细胞来参与宿主对同种异体移植物的反应。我们开展这项研究以确定使用聚合酶链反应方法来界定三种重要细胞因子(肿瘤坏死因子-α、白细胞介素-2和干扰素-γ)在人肺同种异体移植物中表达情况的可行性。
从13例肺移植受者获取26份移植物来源样本(11份经支气管活检样本以及从支气管肺泡灌洗中分离得到的8份巨噬细胞和7份淋巴细胞细胞沉淀),并按如下方式处理:提取RNA;将RNA逆转录为互补DNA;用针对这三种细胞因子的寡核苷酸引物对cDNA进行聚合酶链反应扩增;对聚合酶链反应产物进行凝胶电泳;并用斑点印迹技术(使用特异性32P标记的寡核苷酸探针)验证正确的细胞因子信息。
对这13例受者活检标本进行的同步病理评估显示有五个诊断组:“正常”(无排斥反应/感染),n = 2;急性排斥反应,n = 4;非特异性炎症,n = 3;感染,n = 3;闭塞性细支气管炎,n = 1。白细胞介素-2主要在急性排斥反应和感染中表达(分别为十分之七和六分之五的样本呈阳性),而肿瘤坏死因子-α主要在非特异性炎症中表达(五分之四的样本),在排斥反应中表达略少(十分之六)。干扰素-γ表达频率较低(在六份感染样本中有两份表达,但在十份排斥反应样本中均未表达,在五份非特异性炎症样本中也均未表达)。来自一名患者(相隔6个月)的系列数据显示,随着她从正常组织学状态进展至闭塞性细支气管炎,白细胞介素-2和干扰素-γ表达显著增加。
可从直接来源于肺同种异体移植物的微量样本中确定细胞因子基因转录本。尽管我们的数据不足以得出明确结论,但不同移植后病理状况下细胞因子表达趋势的提示可能表明该方法在肺移植受者的临床评估中具有有用作用。